The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Oral Therapies in Oncology: Cognitive Function and Compliance
Official Title: Oral Therapies in Oncology: Cognitive Function and Compliance
Study ID: NCT01597284
Brief Summary: The investigators propose to evaluate the compliance of oral cancer therapies, particularly the possible link between this observance and cognitive function of patients at initiation of treatment. To our knowledge, this study will be among the first conducted on the issue in France and is an innovative approach in the management of cancer patients. The inclusion of cognitive dysfunction is part of a comprehensive approach to improving the quality of life and fully meets the objectives of both plans cancer, including those of the axis "Living during and after cancer" highlighted in the Cancer Plan
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Centre François Baclesse, Caen, , France
Name: JOLY Florence, PhD
Affiliation: Centre François Baclesse
Role: PRINCIPAL_INVESTIGATOR